vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

Energy Recovery, Inc. is the larger business by last-quarter revenue ($66.9M vs $47.7M, roughly 1.4× IRONWOOD PHARMACEUTICALS INC). Energy Recovery, Inc. runs the higher net margin — 40.2% vs -4.8%, a 45.0% gap on every dollar of revenue. On growth, Energy Recovery, Inc. posted the faster year-over-year revenue change (-0.3% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $6.4M). Over the past eight quarters, Energy Recovery, Inc.'s revenue compounded faster (8.1% CAGR vs -20.2%).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

ERII vs IRWD — Head-to-Head

Bigger by revenue
ERII
ERII
1.4× larger
ERII
$66.9M
$47.7M
IRWD
Growing faster (revenue YoY)
ERII
ERII
+47.0% gap
ERII
-0.3%
-47.3%
IRWD
Higher net margin
ERII
ERII
45.0% more per $
ERII
40.2%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$68.2M more FCF
IRWD
$74.6M
$6.4M
ERII
Faster 2-yr revenue CAGR
ERII
ERII
Annualised
ERII
8.1%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ERII
ERII
IRWD
IRWD
Revenue
$66.9M
$47.7M
Net Profit
$26.9M
$-2.3M
Gross Margin
67.2%
Operating Margin
46.8%
14.3%
Net Margin
40.2%
-4.8%
Revenue YoY
-0.3%
-47.3%
Net Profit YoY
14.7%
-200.9%
EPS (diluted)
$0.49
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
IRWD
IRWD
Q4 25
$66.9M
$47.7M
Q3 25
$32.0M
$122.1M
Q2 25
$28.1M
$85.2M
Q1 25
$41.1M
Q4 24
$67.1M
$90.5M
Q3 24
$38.6M
$91.6M
Q2 24
$27.2M
$94.4M
Q1 24
$12.1M
$74.9M
Net Profit
ERII
ERII
IRWD
IRWD
Q4 25
$26.9M
$-2.3M
Q3 25
$3.9M
$40.1M
Q2 25
$2.1M
$23.6M
Q1 25
$-37.4M
Q4 24
$23.5M
$2.3M
Q3 24
$8.5M
$3.6M
Q2 24
$-642.0K
$-860.0K
Q1 24
$-8.3M
$-4.2M
Gross Margin
ERII
ERII
IRWD
IRWD
Q4 25
67.2%
Q3 25
64.2%
Q2 25
64.0%
Q1 25
Q4 24
70.2%
Q3 24
65.1%
Q2 24
64.6%
Q1 24
59.0%
Operating Margin
ERII
ERII
IRWD
IRWD
Q4 25
46.8%
14.3%
Q3 25
11.4%
61.8%
Q2 25
5.3%
53.2%
Q1 25
-70.7%
Q4 24
38.2%
34.8%
Q3 24
18.3%
28.0%
Q2 24
-7.4%
26.5%
Q1 24
-90.4%
14.7%
Net Margin
ERII
ERII
IRWD
IRWD
Q4 25
40.2%
-4.8%
Q3 25
12.1%
32.8%
Q2 25
7.3%
27.7%
Q1 25
-90.9%
Q4 24
35.0%
2.5%
Q3 24
22.0%
4.0%
Q2 24
-2.4%
-0.9%
Q1 24
-68.3%
-5.6%
EPS (diluted)
ERII
ERII
IRWD
IRWD
Q4 25
$0.49
$0.01
Q3 25
$0.07
$0.23
Q2 25
$0.04
$0.14
Q1 25
$-0.23
Q4 24
$0.40
$0.03
Q3 24
$0.15
$0.02
Q2 24
$-0.01
$-0.01
Q1 24
$-0.14
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$75.2M
$215.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.2M
$-261.8M
Total Assets
$231.5M
$396.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
IRWD
IRWD
Q4 25
$75.2M
$215.5M
Q3 25
$70.4M
$140.4M
Q2 25
$79.5M
$92.9M
Q1 25
$108.5M
Q4 24
$78.0M
$88.6M
Q3 24
$118.6M
$88.2M
Q2 24
$101.0M
$105.5M
Q1 24
$117.4M
$121.5M
Total Debt
ERII
ERII
IRWD
IRWD
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
ERII
ERII
IRWD
IRWD
Q4 25
$206.2M
$-261.8M
Q3 25
$180.8M
$-264.2M
Q2 25
$185.2M
$-308.2M
Q1 25
$-334.1M
Q4 24
$210.0M
$-301.3M
Q3 24
$233.9M
$-311.3M
Q2 24
$218.5M
$-321.7M
Q1 24
$216.0M
$-330.5M
Total Assets
ERII
ERII
IRWD
IRWD
Q4 25
$231.5M
$396.9M
Q3 25
$209.6M
$396.1M
Q2 25
$212.3M
$342.9M
Q1 25
$327.2M
Q4 24
$242.8M
$350.9M
Q3 24
$262.7M
$389.5M
Q2 24
$249.0M
$395.6M
Q1 24
$244.3M
$438.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
IRWD
IRWD
Operating Cash FlowLast quarter
$7.1M
$74.6M
Free Cash FlowOCF − Capex
$6.4M
$74.6M
FCF MarginFCF / Revenue
9.6%
156.3%
Capex IntensityCapex / Revenue
1.0%
0.0%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
IRWD
IRWD
Q4 25
$7.1M
$74.6M
Q3 25
$-3.1M
$47.6M
Q2 25
$4.1M
$-15.1M
Q1 25
$20.0M
Q4 24
$9.0M
$15.2M
Q3 24
$-3.0M
$9.9M
Q2 24
$8.1M
$33.5M
Q1 24
$6.5M
$45.0M
Free Cash Flow
ERII
ERII
IRWD
IRWD
Q4 25
$6.4M
$74.6M
Q3 25
$-3.5M
$47.6M
Q2 25
$4.0M
$-15.1M
Q1 25
$19.9M
Q4 24
$8.9M
Q3 24
$-3.2M
$9.9M
Q2 24
$7.9M
$33.4M
Q1 24
$5.7M
$44.9M
FCF Margin
ERII
ERII
IRWD
IRWD
Q4 25
9.6%
156.3%
Q3 25
-10.9%
39.0%
Q2 25
14.3%
-17.7%
Q1 25
48.4%
Q4 24
13.2%
Q3 24
-8.2%
10.8%
Q2 24
28.9%
35.4%
Q1 24
46.9%
60.0%
Capex Intensity
ERII
ERII
IRWD
IRWD
Q4 25
1.0%
0.0%
Q3 25
1.1%
0.0%
Q2 25
0.5%
0.0%
Q1 25
0.1%
Q4 24
0.2%
0.0%
Q3 24
0.4%
0.0%
Q2 24
0.7%
0.1%
Q1 24
6.8%
0.1%
Cash Conversion
ERII
ERII
IRWD
IRWD
Q4 25
0.26×
Q3 25
-0.81×
1.19×
Q2 25
2.02×
-0.64×
Q1 25
Q4 24
0.38×
6.74×
Q3 24
-0.35×
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

IRWD
IRWD

Segment breakdown not available.

Related Comparisons